| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.032 | 0.9 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.028 | 0.9 |